Portfolio company
Beyond Barriers Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops field-ready intranasal therapeutics for patients suffering from concussions and traumatic brain injuries.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
BE Therapeutics
This company develops engineered brain and spinal cord tissues to repair central nervous system damage for patients with neurodegeneration, stroke or trauma.
CranioSense
This company develops non-invasive diagnostic systems to monitor intracranial pressure for emergency care teams and clinicians treating traumatic brain injuries.
Neuronetix
Neuronetix develops a point-of-care blood test to quantify and objectively diagnose concussions in student athletes and other patients.
ReEmerge, Inc.
ReEmerge develops deep brain stimulation therapy to restore cognitive function for patients with chronic impairments caused by traumatic brain injuries.
Neuraworx
This company develops a wearable neurostimulation device that enhances the brain's waste clearance system to treat neurodegenerative diseases and traumatic brain injuries.
Aliada Therapeutics
This company develops blood-brain barrier crossing technologies and antibody therapies for patients with central nervous system diseases including Alzheimer's.
Carthera
This company develops an ultrasound-based medical device to increase the permeability of the blood-brain barrier for patients with tumours and neurodegenerative diseases.
Oculogica
This company develops eye-tracking tools to help healthcare providers and sports teams diagnose concussions and perform sideline screenings.
